Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions by Lathia, J D et al.
Distribution of CD133 reveals glioma stem cells
self-renew through symmetric and asymmetric cell
divisions
JD Lathia*
,1,10 M Hitomi
1,10, J Gallagher
1, SP Gadani
1, J Adkins
2, A Vasanji
3, L Liu
1, CE Eyler
4, JM Heddleston
1,QW u
1, S Minhas
1,
A Soeda
5,9, DJ Hoeppner
6, R Ravin
6, RDG McKay
6, RE McLendon
7, D Corbeil
8, A Chenn
2, AB Hjelmeland
1, DM Park
5,9 and JN Rich*
,1
Malignant gliomas contain a population of self-renewing tumorigenic stem-like cells; however, it remains unclear how these
glioma stem cells (GSCs) self-renew or generate cellular diversity at the single-cell level. Asymmetric cell division is a proposed
mechanism to maintain cancer stem cells, yet the modes of cell division that GSCs utilize remain undetermined. Here, we used
single-cell analyses to evaluate the cell division behavior of GSCs. Lineage-tracing analysis revealed that the majority of GSCs
were generated through expansive symmetric cell division and not through asymmetric cell division. The majority of
differentiated progeny was generated through symmetric pro-commitment divisions under expansion conditions and in the
absence of growth factors, occurred mainly through asymmetric cell divisions. Mitotic pair analysis detected asymmetric CD133
segregationandnotanyotherGSCmarkerinafractionofmitoses,someofwhichwereassociatedwithNumbasymmetry.Under
growth factor withdrawal conditions, the proportion of asymmetric CD133 divisions increased, congruent with the increase in
asymmetric cell divisions observed in the lineage-tracing studies. Using single-cell-based observation, we provide deﬁnitive
evidence that GSCs are capable of different modes of cell division and that the generation of cellular diversity occurs mainly
through symmetric cell division, not through asymmetric cell division.
Cell Death and Disease (2011) 2, e200; doi:10.1038/cddis.2011.80; published online 1 September 2011
Subject Category: Experimental Medicine
Malignant gliomas (World Health Organization grade III–IV
tumors) are extremelylethal and have a 5-year survival rate of
o3%.
1 Despite aggressive clinical treatment – including
surgical resection, radiation, and chemotherapy – tumor
recurrence is essentially universal. Therapeutic failure is
due, in part, to tumor cell heterogeneity, derived from both
genetic and non-genetic sources,
2 which contributes to
therapeutic resistance and tumor progression. Self-renewing,
tumorigenic stem-like cancer cells have been identiﬁed in
several central nervous system tumors including malignant
gliomas.
3–6 Glioma stem cells (GSCs) are resistant to
radiation
7 and chemotherapy,
8 underscoring the need to
understandtheir biology. Currently, our knowledge ofGSCsis
basedoncomparativestudiesofpopulationsfrombulktumors
enriched or depleted for GSCs. In many studies, populations
ofenrichedcellshavebeenassessedforgrowth,survival,and
tumor formation potential. Such approaches have determined
the importance of GSCs in tumorigenesis and established key
GSC regulators and molecular targets. However, it remains
elusive how GSCs are maintained and generate cellular
diversity, key criteria for consideration as a stem cell.
Additionally, it is unclear which modes of cell division
(symmetric and/or asymmetric) GSCs utilize for tumor
maintenance and the generation of differentiated progeny.
Elegant, single-cell-based studies from the Drosophila
neuroblast system and developing mammalian brain have
demonstrated that the generation of differentiated progeny
from stem/progenitor cells is tightly controlled. This process is
regulated by cell polarity and the segregation of cellular
components indicative of cell fate determination, such as
Numb.
9 Interestingly, studies in the mammalian brain have
shownthatCD133(prominin-1), whichmarksneuralstemand
progenitor cells, is asymmetrically distributed during the
generation of differentiated progeny in the developing
neuroepithelium.
10 Imaging of neural stem/progenitor cells
using single-cell time-lapse microscopy has also led to a
better understanding of lineage speciﬁcation.
11 Several
recent studies in the hematopoietic stem cell system have
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www.nature.com/cddisshown the utility of single-cell time-lapse imaging to delineate
symmetric and asymmetric divisions in response to extrinsic
and intrinsic stimuli
12 and cell fate choice instructed by cyto-
kines.
13 In this report, we used single-cell-based analytical
methods to examine the modes of cell division used to
maintain the GSC population.
Results
Glioma cells originated from a single CD133-positive cell
develop heterogeneity in vivo and in vitro. To examine
single-cell behavior of GSCs, we isolated individual CD133-
positive cells from human glioma specimens. Using the
extracellular matrix (ECM) protein laminin as a substrate,
previously shown to facilitate long-term adherent culture,
14
we expanded the cells over several passages. The long-term
passage of the culture demonstrated consistent, sustained,
logarithmic cell growth, indicating that these culture condi-
tions support GSC cell divisions (Figure 1a). Xenografts
resulting from the expanded cultures had histological hall-
marks of malignant gliomas, including perivascular invasion
(Figures 1b and c), aberrant vasculature (Figure 1d), and
areas of necrosis (Figure 1e). These results conﬁrmed that
Figure 1 Clonal GSCs can be expanded in culture and contain heterogeneity. (a) Population doublings of T4302 A3 clonal cells demonstrated exponential growth over
time starting from 100000 initial cells. (b–e) Representative histology for an intracranial tumor generated from 5000 clonal T4302 A3 cells is shown. Tumors (n¼4/4) formed
withcloneT4302A3.Additionalclonesassayedhadidenticaloutcomes(datanotshown).IntracranialtumorshadtypicalpropertiesofGBM;poorlydeﬁnedtumormargins(b),
inﬁltrating cells (c), aberrant vasculature (d), and regions of necrosis (e). (f) Immunoﬂuorescence micrographs of T4302 A3 GSCs demonstrated that culturing under deﬁned
adherent expansion conditions maintained heterogeneous GSC marker expression (CD133, green; Olig2, red; and marker-negative cells, yellow arrowheads). (g) Neural
(Map2, red) and glial (GFAP, green) differentiation was also detected in these cultures (white arrowhead). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar
indicates 50mm
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Cell Death and Diseasethe in vitro expansion of GSCs supported their growth and
tumorigenic capacity.
To detect heterogeneity within the culture, cells were
stained for stem cell and differentiation markers. The majority
of the clonally derived cells were positive for the stem cell
markers CD133 and Olig2 (Figure 1f). Few cells in the culture,
however, were positive for the glial or neuronal differentiation
markers GFAP or Map2, respectively (Figure 1g, Supple-
mentary Figure 1). These observations suggest that the
culture conditions can maintain GSC propagation with a low
incidence of differentiation, which generates non-stem cells.
Since epidermal growth factor (EGF) and ﬁbroblast growth
factor (FGF) are established critical components of stem cell
culture medium,
15,16 we next removed these growth factors to
determine effects on GSC propagation. As expected, we
observed more frequent differentiation with EGF and FGF
withdrawal (Supplementary Figure 1). Together, these data
support the use of deﬁned cell culture medium, including EGF
and FGF, for maintaining GSCs in the culture.
Time-lapse lineage tracing detected asymmetric cell
division. The expansion of GSCs in our deﬁned cell culture
medium also infrequently generated differentiated progeny,
which represented a small fraction of cells (Figure 1f,
Supplementary Figure 1). To evaluate the emergence of
these differentiated progenies, and understand the expansion
of GSCs at a single-cell resolution, we used time-lapse
lineage tracing to monitor GSC cell divisions (Figure 2). For
these experiments, CD133-positive cells were enriched by
ﬂuorescence-activated cell sorting (FACS) and directly plated
onto culture dishes coated with Geltrex basement membrane
matrix, a laminin-rich ECM substrate. Cell divisions were
recorded with time-lapse microscopy, and cells were subse-
quently ﬁxed and stained for the differentiation markers GFAP
and Map2 (Figure 2a). We identiﬁed cells that had divided
once and analyzed the fate of the resulting daughter cells
(Figure 2a). Differentiation marker-positive cells were scored
as differentiated non-GSCs and differentiation marker-negative
cells as putative GSCs. Through this analysis, we detected
Figure 2 Growth factor withdrawal increased asymmetric cell division in time-lapse lineage tracing. CD133-positive GSCs were enriched by FACS and were plated onto
Geltrex-coated plates in the presence or absence of growth factors. Cell divisions were recorded by time-lapse video microscopy for 42h. At the end of image capturing, cells
wereﬁxedandimmunostainedfordifferentiationmarkersforneural(Map2)andglial(GFAP)lineages.(a)Examplephase(left)andﬂuorescence(right)imagesoftrackingand
immunophenotyping results for daughter cells at the end of a 42-h observation period when Map2 was used as a neural marker. Red and green circles with corresponding
number represent progeny generated from the same parent cell (cell 17 shown as an example). Pixel intensity values normalized to background levels are displayed for each
cellintheﬂuorescencemicrographs.Thescalebarindicates50mm.(b)Analysisoftime-lapsevideomicroscopydetectedfourtypesofcelldivisions.Single-celllineage-tracing
time-lapse microscopy movies demonstrated that growth factor withdrawal (n¼111 cell divisions for EGF and basic FGF conditions, n¼29 cell divisions for growth factor
withdrawal conditions) decreased the number of symmetric stem/progenitor cell divisions and increased the generation of differentiated progeny and cell death. Proportional
comparison of cell division types between conditions indicated a statistically signiﬁcant difference, Po0.05, using Fisher’s exact test. (N, neural marker positive cell (white
arrow); S, stem/progenitor cell (yellow arrow))
CD133 is informative for glioma stem cell division mode
JD Lathia et al
3
Cell Death and Diseasefour distinct modes of cell division: (1) symmetric GSC
expanding division; (2) symmetric differentiating division;
(3) asymmetric self-renewing/differentiating division; and
(4) asymmetric survival/death division (Figure 2b). The vast
majority of GSCs (480%) underwent symmetric division,
which expanded the stem cell population (Figure 2b). Among
the rarer differentiation events, differentiation was threefold
more likely to be induced through symmetric differentiating
division than asymmetric division. A few divisions that
resulted cell death were detected, although this was o1%
of all events in the presence of expansive culture conditions.
When growth factors were removed from the culture during
time-lapse recording, we observed a decrease in symmetrical
stem cell expansion division incidence to o70% of events.
Growth factor withdrawal caused a concomitant ﬁvefold
increase in asymmetric self-renewal/differentiation division
frequency. These data demonstrate that GSCs are capable of
utilizing different modes of cell division to maintain a stem cell
population and GSCs are maintained mainly by symmetric,
not by asymmetric cell divisions.
Asymmetry of CD133 segregation during mitosis.
Asymmetric cell divisions are a major route for stem cells
to give rise to differentiated cells while simultaneously
maintaining a stem cell population. Similarly, asymmetric
cell divisions may have an important role in gliomas to
maintain a GSC pool as well as increase heterogeneity of
tumor cells by generating more differentiated progeny. We
therefore sought to conﬁrm the asymmetric cell division of
GSCs using a method complementary to time-lapse imaging.
Mitotic GSCs were enriched using mitotic shake off following
release from thymidine block, and the segregation pattern
of molecules at the time of mitosis was monitored. We
examined the distribution of a panel of stem cells, GSCs,
and differentiation markers and found that only CD133 was
capable of equal and unequal distribution during mitosis
(Figure 3; data not shown). The symmetric or asymmetric
distribution of CD133 was conﬁrmed with three different
antibodies recognizing separate glycosylated or peptide
epitopes
17 (Supplementary Table 1; Figure 4a). The
analyzed mitotic cells were genuinely dividing, which was
conﬁrmed by a-tubulin staining at cleavage furrows
regardless of CD133 distribution (Figure 4b). Staining for
additional stem cell markers, including integrin-a6,
18
L1CAM,
19 and CD15
20 in combination with CD133, further
conﬁrmed selective asymmetric distribution of CD133
(Figure 5a). However, analysis with the previously deﬁned
asymmetric cell division marker Numb detected asymmetric
segregation in a fraction of mitotic GSCs (Figure 5b).
Distribution of Numb did correlate with CD133 when Numb
showed asymmetry during mitosis (Figure 5b), further
conﬁrming the ability of CD133 to be asymmetrically
distributed. To ensure that the unequal distribution of
CD133 was not an artifact of our enrichment method, we
examined cultures without synchronization or mitotic shake
off. We observed unequal distribution of CD133 in some cells
at each phase of mitosis: prophase, metaphase, anaphase,
and telophase (Supplementary Figure 2).
Todeﬁne the rateof asymmetric cell division, we developed
a control analysis by the segregation pattern of
a-tubulin, a molecule that should not asymmetrically segre-
gate. From quantiﬁcation of a-tubulin distribution between
the two emerging daughter cells, symmetrical division was
deﬁned when the percent deviation of the stained marker
between daughter cells was o25% (see Materials and
Methods for details). Using this criterion, we found that
the percentage of mitoses with asymmetric CD133 distribu-
tion was o30% in cell culture conditions, promoting GSC
propagation (Figure 6b). However, removal of growth factors
increased the frequency of CD133 asymmetric cell division
by at least 44% in GSCs derived from two different gliomas
analyzed with two different CD133 antibodies (Figure 6b).
Thus, GSCs can undergo asymmetric cell division, and their
mode of cell division is impacted by culture conditions using
two independent methods.
Polarized localization of CD133 in interphase GSCs. The
relationship between cell polarity and orientation of cell
division determines whether a neural stem cell undergoes
symmetric or asymmetric cell division during development. In
normal tissue, CD133 associates with cholesterol-rich
membrane microdomains (lipid rafts)
10,21 and localizes to
special subdomains of the plasma membrane of cells.
22
Furthermore, CD133 polarization has been related to cellular
motility and cell division of hematopoietic stem and
progenitor cells.
23 We therefore examined whether CD133
localization is polarized in GSCs to contribute to asym-
metric distribution during mitosis. Asynchronous, actively
proliferating GSC monolayer cultures were ﬁxed and
immunostained for CD133. We detected three types of
CD133 distribution patterns: (1) homogenous expression
throughout the cells; (2) expression limited to a segment(s) of
the cell; and (3) expression localized to scattered patches
(Figures 7a–c). As the cell membrane has ﬂuidity, these
expression patterns may dynamically change. However, one
daughter cell receives higher amounts of CD133 if uneven
distributions of CD133 take place at the time of mitosis.
Indeed, we detected metaphase cells with uneven patchy
concentrations of CD133 on the opposite side of the cell
cleavage line. However, concentration of CD133 to patches
does not necessitate asymmetric distribution of CD133, as
the total sum of CD133 can be equivalently expressed in both
emerging daughter cells (Figures 7d–f). If localized CD133
distribution in the cell membrane is a mechanism of
asymmetric distribution of CD133, the frequency of GSCs
with polarized CD133 would increase under conditions that
induce asymmetric cell division. We therefore determined the
frequency of GSCs with polarized CD133 in the presence
and absence of growth factors (Figure 7g). Under GSC
growth expansive culture conditions, the percentage of cells
expressing polarized CD133 expression was B12%. Growth
factor deprivation resulted in a 65% increase in the fraction of
GSCs with localized CD133 (Figure 7g). This observation
suggests that polarization of CD133 may be an underlying
mechanism of asymmetric CD133 segregation during mitosis.
Taken together, our data demonstrate that using single-cell
analysis of GSCs, we can conﬁrm that they are capable of
self-renewing and generating cellular diversity. Additionally,
GSCs utilize symmetric and not asymmetric divisions for their
CD133 is informative for glioma stem cell division mode
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Cell Death and Diseasepropagation and generation of differentiated progeny under
expansion conditions.
Discussion
Malignant gliomas are aggressive tumors with poor prognosis
due to resistance to therapies. Recent studies indicate that
GSCshavecriticalrolesnotonlyintumorpropagationbutalso
in therapeutic resistance. Using single-cell -based time-lapse
microscopy and quantitative immunoﬂuorescence, we found
that GSCs utilize two cell division modes to generate GSCs.
TheﬁrstmethodistogeneratetwoGSCsthroughasymmetric
cell division, and the other is to generate one GSC and one
non-GSC through an asymmetric cell division. Symmetric
stem cell expanding divisions were more frequent in the
presence of growth factors, suggesting that growth factor
signaling contributes to the expansion of the stem cell
population in the tumor. Upon growth factor deprivation,
asymmetric cell division increased. This division mode would
contribute to increased cellular heterogeneity of the tumor,
while still maintaining a GSC pool. Under conditions of growth
factor withdrawal, asymmetric cell division would provide
the beneﬁt of maintaining the GSC pool by generating a
CD133 high daughter cell with stem cell capability. Although
Figure 3 A screen of stem/progenitor markers on mitotic cell pairs reveals that CD133 is unequally distributed in a fraction of GSCs. Confocal micrographs of mitotic cell
pairs derived from T4302 clone A3 cell populations grown in expansion conditions stained for the indicated markers of stem/progenitor cells (green). Symmetric distribution
between nascent daughter cells was observed for Bmi1, CD15, integrin-a6, L1CAM, Nestin, Olig2, and Sox2. In contrast, CD133 exhibited both symmetric and asymmetric
distributions between progenies (asterisk). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar indicates 5mm
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Cell Death and Diseasegeneration of this GSC would be at the expense of the paired
daughter cell with CD133 low, asymmetric division would
avoid producing two daughter cells with intermediate CD133
levels in higher risk of generating two non-stem cells that
could result from symmetric division.
Among the many molecules we examined, only CD133
and Numb could be asymmetrically segregated. CD133 is
a cell surface marker that enriches GSCs, and CD133 high
cells survive better than CD133 low cells (Supplementary
Figure 3). The fact that other stem cell markers were not
co-segregated with CD133 suggests that there are multiple
factors contributing to GSC maintenance. In support of this
notion, CD15 serves as a GSC marker in CD133-negative
glioma cells.
20 In fact, CD15-positive cells, similar to CD133-
positive cells, survive better and proliferate faster as
compared with their negative counterparts (Supplementary
Figure 3), indicating its potential to complement some part of
CD133 function. In contrast to CD133, Numb is a fate-
determining molecule that promotes the differentiation of
neural stem cells through its ability to antagonize notch and
hedgehog signaling pathways.
24,25 A correlation between
CD133 and Numb was observed during cell divisions with
Numb asymmetry. The daughter cells receiving less Numb
and CD133 can potentially give rise to CD133-negative GSCs
due to attenuated Numb function. Such complex combina-
tions of stem cell markers and Numb inheritance would
contribute to multiple states of GSCs as proposed.
26
When interphase GSCs were stained for CD133, we found
a polarized staining pattern in a fraction of the cells. We also
detected localized CD133 in patches evenly or unevenly
distributed across cell cleavage plane during mitosis. These
data suggest localized CD133 expression and its positioning
againstthemitoticaxisdeterminesasymmetricsegregationof
this molecule. A similar mechanism has been reported for
Figure 4 Equal and unequal distribution of CD133 is observed using various anti-CD133 antibodies. (a) Confocal micrographs of T4302 clone A3 cells revealed that
symmetric and asymmetric distributions of CD133 were detected with multiple CD133 antibodies. W6B3C1 or 80B258 mouse monoclonal antibody (green, mCD133) was
used together with ab19898 rabbit polyclonal antibody (red, rCD133). (b) Confocal micrographs of double staining of CD133 (ab19898, green, rCD133) with a-tubulin (red)
conﬁrmedthatmitoticpairs ofT4302A3clonalcellswereundergoing celldivision.Arrowsindicatethemid-body.Similardatawereobserved withnon-clonalT4121cells(data
not shown). Nuclei were visualized with Hoechst 33342. Scale bar indicates 5mm
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Cell Death and Diseaseasymmetrical segregation of molecules in the apical mem-
braneofneuralstemcells.
10CD133isconcentratedinvarious
plasmamembraneprotrusions,suchasmicrovilli, ﬁlopodia,or
lamellipodia, probably due to its association with cholesterol-
rich membrane microdomains.
21,27 Although it remains
unclear how local CD133 concentration is formed in GSCs,
there are reports on the mechanisms of membrane micro-
domain clustering and polarization. In non-polarized (non-
epithelial) cells, cholesterol-rich membrane microdomains
can form patchy patterns upon crosslinking plasma mem-
brane proteins and/or glycolipids residing in the domain.
28
Membrane microdomains are polarized through cytoskeletal
action in neutrophils upon chemoattractant stimulation.
29
A similar mechanism may regulate the local concentration
of CD133 in GSCs. As growth factor receptors are also
concentrated in membrane microdomains,
30,31 it is possible
that growth factor availability could alter clustering of
membrane microdomains harboring CD133.
Our single-cell-based approach revealed that there are two
cell division modes to generate GSCs. The symmetric
expansion mode will increase the GSC pool in the tumor,
whereas asymmetric cell division will increase cellular
heterogeneity of the tumor while maintaining GSC pool. The
biological signiﬁcance of these two division modes is not yet
fully understood, butit is expected thattherapies thatincrease
asymmetric division would generate decreased numbers of
resistant GSCs and be favorable for patient outcome. We
anticipate the single-cell-based analyses presented here will
be useful to assess drug effects on the mode of cell division.
The information collected could help to develop new thera-
peutic strategies for targeting gliomas by developing a greater
understanding of the regulation of GSC cell fate.
Symmetric CD133 distribution
DNA Integrin 6
L1CAM L1CAM
CD15 CD15
CD133 Numb DNA Phase CD133/Numb/DNA
DNA Integrin 6 CD133 CD133
Asymmetric CD133 distribution
Figure 5 Equal and unequal distribution of CD133 irrespective of other GSC markers, but Numb. (a) Confocal micrographs of mitotic cell pairs derived from T4302 A3
clonal cells grown in expansion conditions demonstrated constant uniform expression patterns for integrin-a6, L1CAM, and CD15 (red). In contrast, symmetric or asymmetric
CD133 distribution was detected using ab19898 rabbit antiserum (green). Identical results were obtained with non-clonal T4121 cells (data not shown). (b) Fluorescent
micrographs of mitotic cell pairs derived from T4302 A3 clonal cell populations grown in expansion conditions demonstrated consistent asymmetric distribution of CD133 and
Numb. Nuclei were counterstained with Hoechst 33342 (blue). Scale bars indicate 5mm for a and 15mm for b
CD133 is informative for glioma stem cell division mode
JD Lathia et al
7
Cell Death and DiseaseMaterials and Methods
Isolation of GSCs and generation of adherent colonies. Cells that
functionally fulﬁlled criteria for GSCs (serial self-renewal, sustained proliferation,
tumor propagation, and stem cell marker expression) were prepared and
maintained as previously described.
4,7,14 Brieﬂy, GSCs were isolated from
surgically obtained glioma specimens, transiently ampliﬁed by implantation of
unsorted tumor cells into immunocompromised mice, and derived xenografts were
dissociated before culture. All specimens were derived from glioma surgical tissues
obtained from patients undergoing resection for a newly diagnosed (T4302) or
recurrent (T4121) glioma in accordance with protocols approved by the Duke
University Medical Center Institutional Review Board. Written consent to utilize
excess tissue for research was obtained from each patient, and tissues were de-
identiﬁed for all studies. Additional information about the tumors is provided in
Supplementary Table 1. For xenograft dissociation, single cells were prepared from
the bulk tumor by a Papain dissociation kit (Worthington Biochemical, Lakewood,
NJ, USA) as per the manufacturer’s protocol and cultured using previously reported
culturing methods. For the generation of adherent colonies, single GSCs were
sorted into marker-positive fractions based on antibodiesagainst CD133 (CD133/2-
allophycocyanin (APC)-conjugated antibody, 293C3, Miltenyi Biotech, Auburn, CA,
USA) using FACS. A single marker-positive cell was plated into each well of a
96-well plate (BD Biosciences, La Jolla, CA, USA) containing neurobasal media
supplemented with B27 (Invitrogen, Carlsbad, CA, USA), 20ng/ml EGF
Figure 6 CD133 asymmetry increased upon growth factor deprivation. (a) Representative phase and ﬂuorescence micrographs of GSCs analyzed during mitosis stained
with rabbit antiserum ab19898 against CD133 (green). Similar images were produced with mouse monoclonal antibody W6B3C1 against CD133 (images not shown). Cells
were counterstained with Hoechst 33342 (blue) to mark DNA. Analysis occurred by comparing pixel intensities of DNA with CD133 staining in the area containing each
emerging daughter cell, as indicated by the red and yellow lines. Examples of symmetrical and asymmetrical distributions of CD133 are shown. Percent deviation in staining
between daughter cells is displayed below micrographs. The scale bar indicates 10mm. (b) Quantiﬁcation of images as illustrated in a demonstrated that withdrawal of EGF
and basic FGF (bFGF) increased the fraction of mitotic pairs with asymmetric CD133 distribution when compared with cultures with EGF and bFGF in both T4121 and T4302
cells. N, number of cell divisions. **Po0.01; ***Po0.001 as assessed using Pearson’s w
2-test
Figure 7 Polarization of CD133 during interphase and mitosis. Actively proliferating glioma cells on Geltrex-coated coverslips were ﬁxed and stained for CD133 using
rabbit antiserum ab19898 (green). Nucleiwere counterstained with Hoechst 33342(blue). (a–c) Polarizedlocalizationof CD133was detectedin a fractionof interphasecells,
asindicatedbyyellowarrows.However,manycellscontaineddiffuseCD133staining,asindicatedbywhitearrows.(d–f)PolarizedlocalizationofCD133wasalsosometimes
detected during mitosis. (d) Each daughter cell would receive similar total amounts of CD133 when CD133 was evenly distributed throughout the dividing cells. (e) When
CD133ispolarizedduringdivision,daughtercellscouldreceivedivergentamountsofCD133ifexpressionswereasymmetricallydistributed.(f)EvenwhenCD133ispolarized
duringmitosis,daughtercellscouldreceivesimilaramountsofCD133ifexpressionswereequallydistributed.Thescalebarsindicate20mmfora–cand10mmford–f.(g)The
frequency of interphase cells with polarized CD133 distribution increased when growth factors were deprived from culture media. N, number of cells analyzed. **Po0.02
(P¼0.0146) by Pearson’s w
2 analysis
CD133 is informative for glioma stem cell division mode
JD Lathia et al
8
Cell Death and DiseaseCD133 is informative for glioma stem cell division mode
JD Lathia et al
9
Cell Death and Disease(R&D Systems, Minneapolis, MN, USA), 20ng/ml basic FGF (R&D Systems), and
5mg/ml laminin (mouse EHS sarcoma laminin, Millipore, Billerica, MA, USA or
Sigma,St. Louis, MO, USA) using a FACS Aria II (BD Biosciences) equippedwith a
100mm nozzle with low sheath pressure. Adherent clonal colonies were fed every
week and expanded from a 96-well plate to 10cm tissue culture dishes via 24- and
6-well tissue culture plates (BD Biosciences). Although the colony formation
efﬁciencywas lower for free ﬂoating tumorspheres, as has been reportedby Pollard
and co-workers,
14 colonies that were generated from either adherent or non-
adherent culture conditions gave rise to populations of cells that efﬁciently formed
tumors when transplanted in vivo (data not shown).
Immunoﬂuorescence. For immunoﬂuorescence analysis of adherent cultures,
cells were ﬁxed with 2% paraformaldehyde (Sigma) at room temperature for 15min,
washedwiththreetimeswithphosphate-bufferedsaline(PBS),andblockedwith10%
normal goat serum (Sigma) in PBS. Depending on the analysis marker, 0.1% Triton
X-100 (Sigma) was added into the blocking buffer for cell permeabilization to detect
intracellular antigens. Cells were blocked for 30min at room temperature and
incubated with appropriate primary antibodies overnight at 41C. A detailed list of
antibodies can be found in Supplementary Table 2. Cells were washed three times
with PBS and incubated with the appropriate secondary antibody (1:400, goat Alexa
488- or 568-conjugated antibody (IgG), Invitrogen). Nuclei were counterstained with
Hoechst 33342 (5mg/ml in PBS, Invitrogen) and coverslipped before imaging.
Fluorescence micrographs were acquired using a Leica DMI3000B microscope
(Leica Microsystems GmbH, Wetzlar, Germany) with a  20 objective, confocal
micrographs were acquired using a Leica SP5 confocal microscope with a  63
objective, and images were processed and assembled in Photoshop CS (Adobe,
San Jose, CA, USA).
Flow cytometry analysis. For ﬂow cytometry analysis, cells were expanded
inadherentculture,collected,andevaluatedonaCoulterEPICScytometer(Beckman
Coulter, Brea, CA, USA) or a FACS Aria II (BD Biosciences) using PE- or APC-
conjugated CD133/1 (AC133, Miltenyi Biotech), CD15-FITC-conjugated (BD
Biosciences), and Annexin V-FITC-conjugated (BD Biosciences) antibodies,
according to the manufacturers’ recommendations. Appropriate compensation
and isotype controls were used.
Mitotic cell collection and analysis. To collect mitotic cells, adherent
cultures grown on Geltrex (Invitrogen)-coated plates were synchronized with 2mM
thymidine for 12–15h. At 10–15h following release from thymidine block by three
times washing with PBS and changing media with or without growth factors, the
mitotic cells were shaken off the plates by vortexing for 30s. Detached cells were
collected and settled onto poly-L-lysine-coated coverslips at the bottom of
the 6-well plates using centrifugation at 1000r.p.m. for 5min at room temperature.
A minimum of 30 pairs of mitotic cells were analyzed per GSC marker. For
immunoﬂuorescence analysis, cells were ﬁxed, blocked, and stained as described
abovewithorwithoutpermeabilization.Fluorescencemicrographsfor aminimumof
30 ﬁelds per GSC marker were acquired using a Leica (DMI3000B)  20 objective,
and images were processed and assembled in Photoshop CS (Adobe). Confocal
micrographs (composite Z-stacks built from 100nm optical sections) were obtained
using a  63 oil immersion objective with a Leica SP-5 microscope. Images were
processed and assembled in Photoshop CS (Adobe).
Mitotic image analysis. To quantify the degree of asymmetric distribution of
molecules of interest between the two daughter cells, the intensity of ﬂuorescence
immunostaining was determined for each emerging daughter cell. Images of late
anaphase to telophase were collected by ﬂuorescence microscopy as described
above.Thedividingdaughtercellsweredeﬁnedusingthemorphologyofthephase-
contrasted image together with condensed DNA detected by Hoechst 33342
staining.a-Tubulinimmunoﬂuorescencestainingwasalsoutilizedtoidentifydividing
daughter cells. Using ImageJ (NIH, Bethesda, MD, USA), each identiﬁed daughter
cell in a dividing pair was enclosed with the polygon tool, and the integrated
ﬂuorescent signals of the deﬁned daughter cells were determined for DNA and
stained markers.
Statistical analysis. In order to quantify the asymmetry, we calculated
percent (%) deviation of the distribution of the stained markers as follows:
ðF1   F2Þ
F1 þ F2
 100
where F1 and F2 represent the integrated ﬂuorescent values of a given staining for
two dividing daughter cells. As a-tubulin is a critical part of the cell division
machinery, both daughter cells should have strong and equal expression.
Therefore, we set the asymmetry cell division cutoff to be greater than the 99%
conﬁdence interval of a-tubulin (for a bell-shaped distribution, this calculates to the
mean difference±2.576 standard deviation). We calculated the mean
distribution of a-tubulin for a minimum of 100 cells to be 6.668% and the
standard deviationto be 6.655. For these values, we set the asymmetry cutoff to be
greater than a 25% difference between daughter cells, which represents greater
than the 99% conﬁdence interval for a-tubulin as detailed above. After determining
percent (%) deviation for each dividing pairs, each cell division was categorized as
symmetrical or asymmetrical using the 25% difference cutoff value. From four
independent shake-off experiments, the variance in percent (%) deviation was
determined for each treatment and categorical measures were summarized using
frequencies and percentiles. To assess the association between the categorical
variables, Pearson’s w
2-test or Fisher’s exact test was applied to cumulative
categorized cell divisions data collected from four independent shake-off
experiments. All tests were performed at a signiﬁcance level of 0.05. SAS 9.2
software (SAS Institute, Cary, NC, USA) was used for all analyses.
Time-lapse microscopy. T4302 A3 adherent clonal cells were grown in
24-well dishes and imaged on a Leica DMIRB Inverted Microscope equipped for
time-lapse microscopy with a Roper Scientiﬁc CoolSNAP HQ Cooled CCD camera
(Roper Scientiﬁc, Tucson AZ, USA), temperature controller (371C) and CO2 (5%)
incubation chamber (Leica Microsystems GmbH), PeCon incubator (PeCon GmbH,
Erbach, Germany), Prior motorized stage with linearly encoded controller with x/y/z
drive for time-lapse imaging of multiple ﬁelds and heating insert for 12-well plates
(Prior Scientiﬁc Inc., Rockland, MA, USA), Uniblitz shutter (Vincent Associates,
Rochester,NY, USA),and MetaMorphSoftware(MolecularDevices,Downingtown,
PA, USA). Images of multiple ﬁelds per well were collected every 3min for B23h
usinga dry  10, 0.3 NA objective lens,and phase-contrastoptics. For CD15 time-
lapse microscopy, immunostaining and lineage analysis were performed as
described.
11 For statistical analysis of CD15 data, the dividing cell pool was
analyzed separately from the non-dividing cell pool.
Lineage analysis. Phase-contrast, time-lapse image stacks consisting of 857
frames (3min time intervals) were imported into Image-Pro Plus (v6.2, Media
Cybernetics, Silver Spring, MD, USA). Lineage analysis was performed in a
semiautomated manner using customized visual basic Image-Pro Plus macros.
Brieﬂy,eachframeofastackwasﬂattenedtoremoveregionsofunevenillumination
andenhanceappearanceofcellboundaries.Aspectralﬁlter(highpass)followedby
a morphological ‘closing’ ﬁlter (11 11 kernel) was then applied to preferentially
enhance the appearance of cells that were lifting from the plate surface and
rounding. Using morphological (aspect ratio, cell area, and heterogeneity) and
intensity-based selection criteria, these rounded cells were subsequently
segmented from the original sequence as binary objects. Because cells in the
process of dividing/dying may remain rounded in multiple frames before separation/
apoptosis, a search algorithm was applied to the binary stack that examined each
rounded cell and removed every instance of a similar sized cell for the subsequent
100 frames within a 75 75mm region of interest (ROI) around the rounded cell’s
centroid. This ensured that each division/death was only counted once. To classify
rounding cells as dying, dividing, or neither, a similar algorithm was applied that
searched for multiple objects (2 for dividing cells, 42 for apoptotic debris, 1 for
neither) within the originating rounded cell’s ROI. This particular pass utilized user
inputtoconﬁrmclassiﬁcation.Finally,usingacombinationofFouriercorrelationand
user-guidedinput,progenyfollowingeachdivisionweretracedfromtheappearance
of rounding to the last frame or frame in which the cell left the ﬁeld of view or died.
Cell-tracing coordinates and corresponding classiﬁcations were automatically
exported to Excel and pseudo-colored, ﬁnal frame images of surviving progeny as
wellastracingpathssequencesweresavedforeachstack.Forthedeterminationof
the mode of cell division(asymmetric or symmetric), cells were ﬁxedand stained for
Map2,aneuronaldifferentiationmarker,andGFAP,aglialdifferentiationmarker,by
indirect immunoﬂuorescence. The pixel intensities of stained cells were measured
by ImageJ after enclosing each cell with the polygon tool. A mean value of above
300 was established by visual conﬁrmation as positive staining, and asymmetric
divisions were scored when one daughter cell has a mean pixel intensity of above
300 and the other was 300 or below, and at the same time the difference in mean
intensities between the daughter cells was at least 25%.
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